Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
J Registry Manag ; 49(4): 153-160, 2022.
Article in English | MEDLINE | ID: mdl-37260815

ABSTRACT

Cancer surveillance at the population level is a highly labor-intensive process, with certified tumor registrars (CTRs) manually reviewing medical charts of cancer patients and entering information into local databases that are centrally merged and curated at state and national levels. Registries face considerable challenges in terms of constrained budgets, staffing shortages, and keeping pace with the evolving national and international data standards that are essential to cancer registration. Advanced informatics methods are needed to increase automation, reduce manual efforts, and to help address some of these challenges. The Cancer Informatics Advisory Group (CIAG) to the North American Association of Central Cancer Registries (NAACCR) board was established in 2019 to advise of external informatics activities and initiatives for long-term strategic planning. Reviewed here by the CIAG are current informatics initiatives that were either born out of the cancer registry field or have implications for expansion to cancer surveillance programs in the future. Several areas of notable activity are presented, including an overview of informatics initiatives and descriptions of 12 specific informatics projects with implications for cancer registries. Recommendations are also provided to the registry community for the continued tracking and impact of the projects and initiatives.


Subject(s)
Neoplasms , Humans , Certification , Health Personnel , Information Systems , Neoplasms/epidemiology , Registries
2.
Drugs Aging ; 38(9): 817-828, 2021 09.
Article in English | MEDLINE | ID: mdl-34309807

ABSTRACT

PURPOSE: The aim of this study was to examine whether use of regular aspirin and/or other non-steroidal anti-inflammatory drugs (NSAIDs) is associated with the development of age-related macular degeneration (AMD). METHODS: In the California Teachers Study cohort (N = 88,481) we identified diagnoses of AMD up to December 31, 2012 by linkage to statewide hospital discharge records. Aspirin, ibuprofen, other NSAIDs, and acetaminophen use and comprehensive risk factor information were collected via self-administered questionnaires at baseline in 1995-1996 and a follow-up questionnaire in 2005-2006. We employed Cox proportional hazard regression to model AMD risk. RESULTS: We did not find any associations between AMD and frequency and duration of aspirin or ibuprofen use reported at baseline. In the subsample with more specific information on medication use, we observed a 20% decrease in risk of AMD among low-dose aspirin users (HR 0.81, 95% CI 0.70-0.95) and a 55% decrease among cyclooxygenase-2 (COX-2) inhibitor users (HR 0.45, 95% CI 0.26-0.78) during 6.3 years of average follow-up. CONCLUSION: The decrease in risk of intermediate- or late-stage AMD among women who reported regular use of low-dose aspirin or specific COX-2 inhibitors suggests a possible protective role for medications with COX-2 inhibitory properties or aspirin at doses used for cardiovascular disease prevention.


Subject(s)
Macular Degeneration , Pharmaceutical Preparations , Anti-Inflammatory Agents, Non-Steroidal , Aspirin , Female , Humans , Longitudinal Studies , Macular Degeneration/epidemiology , Macular Degeneration/prevention & control , Risk Factors
3.
J Hum Hypertens ; 34(8): 568-576, 2020 09.
Article in English | MEDLINE | ID: mdl-31595025

ABSTRACT

Sustained and inadequately controlled hypertension can promote the development of age-related macular degeneration (AMD) through multiple biologic pathways. Epidemiologic studies of high blood pressure, antihypertensive therapies, and the risk of AMD thus far have been inconclusive. However, few studies evaluated risks according to the use of different classes of antihypertensive drugs or took combinations of use into account. We performed a prospective cohort study by linking the California Teachers Study (CTS) cohort (N = 88 481) to statewide hospital discharge records up to December 31, 2012. History of high blood pressure, regular use of antihypertensive medications, and comprehensive risk factor information was collected via self-administered questionnaires at baseline in 1995-1996, and information on specific classes of antihypertensive drugs was provided by a subsample of CTS participants who completed a follow-up questionnaire in 2000. We identified 1762 female teachers with AMD during 14.8 years of follow-up on average. Applying Cox proportional hazard regression, we estimated increased risks of AMD among women treated for hypertension at baseline (HR = 1.15, 95% CI: 1.03, 1.30); the magnitude of the association increased with longer duration of antihypertensive treatment. In the subsample with more specific information on type of medication use, we estimated a 45% increased risk of AMD among women receiving diuretics as monotherapy compared to women with medications more potent than diuretics (HR = 1.45, 95% CI 1.10, 1.90). In women treated with a combination of antihypertensive drugs, we observed no increased risk of AMD for any individual class of drugs.


Subject(s)
Hypertension , Macular Degeneration , Antihypertensive Agents/adverse effects , Cohort Studies , Female , Humans , Hypertension/drug therapy , Hypertension/epidemiology , Macular Degeneration/chemically induced , Macular Degeneration/drug therapy , Macular Degeneration/epidemiology , Prospective Studies , Risk Factors
4.
Am J Prev Med ; 33(2): 134-6, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17673101

ABSTRACT

BACKGROUND: This study evaluates linkage algorithms used in 1997 for Los Angeles County by the AIDS-Cancer Match Registry to estimate the risk of cancer among people with HIV/AIDS. METHODS: In 2001, a linkage between the Los Angeles County cancer and AIDS registries using a five-pass algorithm was compared with the 1997 linkage results that used a two-pass algorithm. RESULTS: The five-pass linkage detected all of the previously identified matches (6571) as well as another 431 (6.2%), which had been missed. CONCLUSIONS: Record linkage methodologic decisions can markedly affect matching sensitivity and specificity. It is probable that the AIDS-Cancer Match Registry two-pass linkage has underestimated the risks of some cancers among people with AIDS.


Subject(s)
Acquired Immunodeficiency Syndrome/epidemiology , Algorithms , Information Systems , Neoplasms/epidemiology , Comorbidity , Databases as Topic/organization & administration , Humans , Los Angeles/epidemiology , Registries , Risk Factors , United States/epidemiology
5.
Am J Epidemiol ; 165(7): 802-13, 2007 Apr 01.
Article in English | MEDLINE | ID: mdl-17210953

ABSTRACT

Dietary phytochemical compounds, including isoflavones and isothiocyanates, may inhibit cancer development but have not yet been examined in prospective epidemiologic studies of ovarian cancer. The authors have investigated the association between consumption of these and other nutrients and ovarian cancer risk in a prospective cohort study. Among 97,275 eligible women in the California Teachers Study cohort who completed the baseline dietary assessment in 1995-1996, 280 women developed invasive or borderline ovarian cancer by December 31, 2003. Multivariable Cox proportional hazards regression, with age as the timescale, was used to estimate relative risks and 95% confidence intervals; all statistical tests were two sided. Intake of isoflavones was associated with lower risk of ovarian cancer. Compared with the risk for women who consumed less than 1 mg of total isoflavones per day, the relative risk of ovarian cancer associated with consumption of more than 3 mg/day was 0.56 (95% confidence interval: 0.33, 0.96). Intake of isothiocyanates or foods high in isothiocyanates was not associated with ovarian cancer risk, nor was intake of macronutrients, antioxidant vitamins, or other micronutrients. Although dietary consumption of isoflavones may be associated with decreased ovarian cancer risk, most dietary factors are unlikely to play a major role in ovarian cancer development.


Subject(s)
Diet , Ovarian Neoplasms/epidemiology , Adult , Aged , Antioxidants/administration & dosage , California/epidemiology , Female , Humans , Isoflavones/administration & dosage , Micronutrients/administration & dosage , Middle Aged , Ovarian Neoplasms/etiology , Proportional Hazards Models , Prospective Studies , Risk Factors
6.
Cancer Causes Control ; 18(1): 91-103, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17186425

ABSTRACT

OBJECTIVE: Whether alcohol consumption influences ovarian cancer risk is unclear. Therefore, we investigated the association between alcohol intake at various ages and risk of ovarian cancer. METHODS: Among 90,371 eligible members of the California Teachers Study cohort who completed a baseline alcohol assessment in 1995-1996, 253 women were diagnosed with epithelial ovarian cancer by the end of 2003. Multivariate Cox proportional hazards regression analysis was performed to estimate relative risks (RRs) and 95% confidence intervals (CIs). RESULTS: Consumption of total alcohol, beer, or liquor in the year prior to baseline, at ages 30-35 years, or at ages 18-22 years was not associated with risk of ovarian cancer. Consumption of at least one glass per day of wine, compared to no wine, in the year before baseline was associated with increased risk of developing ovarian cancer: RR = 1.57 (95% CI 1.11-2.22), P (trend) = 0.01. The association with wine intake at baseline was particularly strong among peri-/post-menopausal women who used estrogen-only hormone therapy and women of high socioeconomic status. CONCLUSIONS: Alcohol intake does not appear to affect ovarian cancer risk. Constituents of wine other than alcohol or, more likely, unmeasured determinants of wine drinking were associated with increased risk of ovarian cancer.


Subject(s)
Alcohol Drinking , Ovarian Neoplasms/epidemiology , Wine , Adolescent , Adult , Aged , Aged, 80 and over , California/epidemiology , Cohort Studies , Female , Humans , Multivariate Analysis , Ovarian Neoplasms/etiology , Postmenopause/metabolism , Registries , Risk Factors , Socioeconomic Factors
7.
J Natl Cancer Inst ; 97(11): 805-12, 2005 Jun 01.
Article in English | MEDLINE | ID: mdl-15928301

ABSTRACT

BACKGROUND: Epidemiologic studies of the association between nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and ibuprofen, and breast cancer risk have yielded inconsistent results. We investigated the association of NSAID use with risk of breast cancer in the California Teachers Study cohort, with special attention to risk of specific breast cancer subtypes and to type of NSAID used. METHODS: We analyzed data on 114 460 women in the California Teachers Study cohort who were aged 22 to 85 years and free of breast cancer at baseline in 1995 to 1996. Information on frequency and duration of NSAID use was collected through a self-administered questionnaire. A total of 2391 women were diagnosed with breast cancer during the follow-up period from 1995 to 2001. We used Cox proportional hazards regression to estimate relative risks (RR) and 95% confidence intervals (CI) of breast cancer subtypes with NSAID use. RESULTS: Neither regular use (more than once a week) of any NSAID (aspirin and ibuprofen combined) nor regular use of aspirin was associated with breast cancer risk (RR = 1.09, 95% CI = 0.97 to 1.21 for daily versus no regular use of NSAIDs and RR = 0.98, 95% CI = 0.86 to 1.13 for daily versus no regular use of aspirin). However, long-term (> or = 5 years) daily aspirin users had a non-statistically significant decreased risk of estrogen receptor and progesterone receptor (ER/PR)-positive breast cancer (RR = 0.80, 95% CI = 0.62 to 1.03). In contrast, we observed a statistically significantly increased risk of ER/PR-negative breast cancer with long-term daily use of aspirin (RR = 1.81, 95% CI = 1.12 to 2.92). In this population, 11 fewer ER/PR-positive breast cancer cases and seven excess ER/PR-negative breast cancer cases may be due to daily long-term aspirin use among 2391 breast cancer cases observed over 6 years if the association were proven to be causal. Long-term daily use of ibuprofen was also associated with an increased risk of breast cancer (RR = 1.51, 95% CI = 1.17 to 1.95), particularly of nonlocalized tumors (RR = 1.92, 95% CI = 1.24 to 2.97). If causality were subsequently proven, 16 of the observed 2391 breast cancer cases and 8 of the 713 non-localized breast cancer cases would be attributable to long-term daily use of ibuprofen. CONCLUSIONS: Long-term daily use of NSAIDs was not associated with breast cancer risk overall. Ibuprofen use was associated with an increased risk of breast cancer, and long-term daily aspirin use was associated with an increased risk of ER/PR-negative breast cancer. However, it is not clear if the observed association is causal.


Subject(s)
Acetaminophen/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Breast Neoplasms/epidemiology , Breast Neoplasms/pathology , Receptors, Estrogen/analysis , Receptors, Progesterone/analysis , Acetaminophen/adverse effects , Adult , Aged , Aged, 80 and over , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Aspirin/administration & dosage , Breast Neoplasms/chemically induced , Breast Neoplasms/chemistry , California/epidemiology , Faculty/statistics & numerical data , Female , Humans , Ibuprofen/administration & dosage , Incidence , Likelihood Functions , Middle Aged , Neoplasm Staging , Proportional Hazards Models , Prospective Studies , Registries , Research Design , Risk Assessment , Risk Factors , Surveys and Questionnaires
8.
Cancer Epidemiol Biomarkers Prev ; 13(3): 405-11, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15006916

ABSTRACT

Alcohol consumption of approximately two drinks or more per day has been associated with elevated breast cancer risk in the California Teachers Study cohort as well as in many other populations. The objective of this analysis is to examine effects of age at drinking and drinking patterns and to identify effect modifiers. Of the 103,460 at-risk cohort members, age <85, who resided in California and completed the baseline alcohol assessment, 1,742 were diagnosed with invasive breast cancer after joining the cohort and before January 2001. Incident breast cancers were identified through the California Cancer Registry and follow-up for death and confirmation of continued California residence used various sources. Multivariate Cox proportional hazards regression models were used to estimate relative risks (RRs). Elevated breast cancer risk was most evident for recent drinking [RR = 1.28, 95% confidence interval (CI): 1.06-1.54 for >/=20 g/day versus nondrinkers], with no clear pattern for consumption during earlier periods of life. This elevation in risk was 32% among postmenopausal women (95% CI: 1.06-1.63) and 21% among pre/perimenopausal women (95% CI: 0.76-1.92). Highest risks associated with heavy alcohol consumption were observed among postmenopausal women with a history of biopsy-diagnosed benign breast disease (RR = 1.97, 95% CI: 1.39-2.79 compared to nondrinkers without benign breast disease) or who had used combination hormone replacement therapy (HRT) (RR = 2.24, 95% CI: 1.59-3.14 compared to nondrinkers who never used HRT). Recent alcohol consumption equivalent to two or more drinks per day increases the risk of invasive breast cancer, with the greatest RRs observed among heavy drinkers who are also postmenopausal and have a history of benign breast disease or who use HRT.


Subject(s)
Alcohol Drinking/adverse effects , Breast Neoplasms/epidemiology , Breast Neoplasms/etiology , Hormone Replacement Therapy/adverse effects , Registries/statistics & numerical data , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Breast Diseases/complications , Breast Diseases/pathology , California/epidemiology , Cohort Studies , Female , Humans , Middle Aged , Multivariate Analysis , Postmenopause , Risk Factors
9.
Am J Epidemiol ; 158(10): 1012-20, 2003 Nov 15.
Article in English | MEDLINE | ID: mdl-14607810

ABSTRACT

Determining an accurate method of obtaining complete morbidity data is a long-standing challenge for epidemiologists. The authors compared the accuracy and completeness of existing California hospital discharge data with self-reports of recent hospitalizations and surgeries from participants in the California Teachers Study. Self-reports were collected by questionnaire in 1997 from 91433 female teachers and administrators residing in California. Of the 13430 hospital discharge diagnoses identified for these women, cohort members reported 58%. Self-reporting was highest for neoplasms and musculoskeletal and connective tissue diseases and was most accurate for scheduled admissions, more recent admissions, longer lengths of stay, and less severe disorders. Hospitalizations for mental health and infectious disease were not as well reported. Among the 26383 self-reports-including outpatient surgeries, which are not captured by the hospital discharge database-confirmation was lower, as expected, especially for disorders of the nervous system and sense organs and skin and subcutaneous tissue. Confirmation was highest for childbirth admissions. The hospital discharge database was more specific, but the self-reports were more comprehensive, since many conditions are now treated in outpatient settings. The combination of self-reports and secondary medical records provides more accurate and complete morbidity data than does use of either source alone.


Subject(s)
Data Collection/methods , Faculty/statistics & numerical data , Health Care Surveys/methods , Hospitalization/statistics & numerical data , Patient Discharge/statistics & numerical data , Surveys and Questionnaires/standards , Aged , California/epidemiology , Data Collection/standards , Databases, Factual/standards , Female , Health Care Surveys/standards , Humans , International Classification of Diseases/statistics & numerical data , Length of Stay/statistics & numerical data , Logistic Models , Medical Records/standards , Middle Aged , Morbidity , Population Surveillance/methods , Prospective Studies , State Health Planning and Development Agencies/statistics & numerical data , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...